GEORGE COLEMAN: Open Payments
NPI 1801241104 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 17 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $82 |
| Indivior Inc. | 4 | $75 |
| Vanda Pharmaceuticals Inc. | 2 | $66 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Lundbeck LLC | 1 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Braeburn Inc. | 1 | $22 |
| Alkermes, Inc. | 1 | $20 |
| Bausch Health US, LLC | 1 | $18 |
Products named: CAPLYTA, SUBLOCADE, HETLIOZ, Auvelity, REXULTI, UZEDY, SPRAVATO, BRIXADI.
Industry payments across NC — which companies pay providers there.
